1. Preventing Postoperative Recurrence in Crohn’s Disease: What Does the Future Hold?

   • Lucine Vuitton
   • Stéphane Koch
   • Laurent Peyrin-Biroulet

   Current Opinion 17 October 2013 Pages: 1749 - 1759

   

2. Current Management of Iron Deficiency Anemia in Inflammatory Bowel Diseases: A Practical Guide

   • Fernando Gomollón
   • Javier P. Gisbert

   Therapy in Practice 11 October 2013 Pages: 1761 - 1770

3. Current and Emerging Options for the Drug Treatment of Narcolepsy

   • Alberto K. De la Herrán-Arita
   • Fabio García-García

   Review Article 12 October 2013 Pages: 1771 - 1781

4. Alternative Delivery Systems for Agents to Treat Acute Agitation: Progress to Date

   • Kimberly Nordstrom
   • Michael H. Allen

   Review Article 23 October 2013 Pages: 1783 - 1792

   

5. Immunosuppression and Allograft Rejection Following Lung Transplantation: Evidence to Date

   • Gregory I. Snell
   • Glen P. Westall
   • Miranda A. Paraskeva

   Review Article 19 October 2013 Pages: 1793 - 1813

   

6. Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis

   • Kate McKeage

   Adis Drug Evaluation 06 November 2013 Pages: 1815 - 1827

   

7. Telavancin: A Review of Its Use in Patients with Nosocomial Pneumonia

   • Lesley J. Scott

   Adis Drug Evaluation 05 November 2013 Pages: 1829 - 1839

   

8. Olodaterol: First Global Approval

   • Andrew Gibb
   • Lily P. H. Yang

   R&D Insight Report 26 October 2013 Pages: 1841 - 1846

   

9. Erratum to: Canagliflozin: First Global Approval

   • Shelley Elkinson
   • Lesley J. Scott

   Erratum 30 October 2013 Pages: 1847 - 1847